Open AccessIvacaftor – das erste Medikament zur kausalen Therapie der zystischen Fibrose
Author(s) -
Nina LenherrTaube,
Linn Krueger,
Marco Lurà,
Philipp Latzin,
Carmen Casaulta,
Jürg Hammer
Publication year - 2014
Publication title -
swiss medical forum ‒ schweizerisches medizin-forum
Language(s) - German
Resource type - Journals
eISSN - 1424-4020
pISSN - 1424-3784
DOI - 10.4414/smf.2014.02076
Subject(s) - medicine , ivacaftor , cystic fibrosis , cystic fibrosis transmembrane conductance regulator
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom